Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

SR-271425: new thioxanthone with promising preclinical antitumor activity

April 13, 1999

Second-generation RAMBA selected by Janssen as development candidate

April 13, 1999

Pierre Fabre features topoisomerase inhibitor in several AACR presentations

April 13, 1999

News from AACR meeting: NCI evaluating new aminoflavone in preclinical studies

April 13, 1999

News from AACR: DNA topoisomerases as a preferred target for new anticancer drugs

April 13, 1999

Abbott's A-105972: new antimitotic agent presented at AACR meeting

April 13, 1999

Warner-Lambert prepares naphthyridinone kinase and cell proliferation inhibitors

April 13, 1999

Xenova presents novel topoisomerase inhibitor at AACR

April 13, 1999

Multiple mechanisms of cytotoxic activity described for FR-901228

April 13, 1999

Pharmacokinetic evaluation of CDK inhibitor indicates need for short dosing interval

April 13, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...